Calcium Chloride (E509) CAS: 10043-52-4
Related Insights
6,000 Seafarers Stranded as Hormuz Traffic Drops, Fueling Shipping Crisis
Approximately 6,000 seafarers are trapped in the Gulf as vessel movements through the Strait of Hormuz fall below normal levels. This bottleneck is not only an operational headache for shipping lines but also a humanitarian crisis and a threat to the chemical supply chain that fuels global commerce. The article explores the ripple effects across maritime logistics, crew welfare, and chemical transport.
Force Majeure Declarations Loom: What Chemical Procurement Teams Should Know About Contract Risk
Prolonged geopolitical disruption is increasing the likelihood of force majeure declarations across energy and chemical supply chains. Procurement and legal teams should review contracts, supplier obligations and contingency plans before disruptions escalate.
Government-Backed Shipping Insurance: Could New Risk Schemes Stabilize Gulf Chemical Trade?
The withdrawal of P&I insurance during the earlier Hormuz disruption sparked discussion about government-backed insurance solutions for commercial shipping. Chemical procurement and compliance teams should understand how future insurance frameworks could influence freight costs and supply chain resilience.
The Red Sea Double Closure and Food Ingredient Logistics: How Two Blocked Corridors Are Reshaping Europe-Asia Supply Chains
The Red Sea double closure continues to reshape food ingredient logistics between Asia and Europe despite improving Gulf shipping conditions. Procurement teams now face longer transit times, higher freight costs and new sourcing strategies as Cape routing remains the only practical option.
MEG: The 6.5 Million Tonne Gulf Export That Reshaped Asian Polyester Supply Chains
The disruption of Gulf MEG exports has transformed procurement strategies across Asia's polyester industry. As shipments begin moving again, buyers must understand transit timelines, supply recovery patterns and pricing risks before inventories normalize.
Drug Shortage Risk Intelligence: June 24 Status Update
Drug shortage risk remains elevated in H2 2026 despite easing Hormuz tensions. Pharmaceutical procurement teams should prioritize safety stock updates, secondary supplier qualification, and stronger force majeure protections to secure supply continuity into 2027.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.